ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

November 24, 2006

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014

CCOP Review Competed, Enough Good Applications In Funding Range To Get Viable Program Started

February 18, 1983

FDA Proposes To Require Electronic Submission

May 3, 2002

Coalition Opens Web Site To Promote Cancer Trials.

June 15, 2001